Advertisement
Advertisement
AKBA
Akebia Therapeutics, Inc.
0.40
USDSponsored
-0.02
-5.69%
Nov 06, 15:59 UTC -5
Closed
After-Market
0.41
0.00
+0.92%
Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. Financial Snapshot
| Market Cap | 112.45M |
| Beta | 0.24 |
| Earnings Per Share (EPS) | -0.16 |
| Price-to-Book (P/B) Ratio | 4.30 |
| Operating Margin | -20.92% |
| Total Debt/Equity (D/E) | 198.11% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -145.58% |
| Current Ratio | 1.43% |
| Free Cash Flow | -18.82M |
